IP Library › Granted Patent US 11,999,706
Granted Patent B1
US 11,999,706 · App. 18/486,898 · Granted Jun 4, 2024

4-chloro-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound

Inventors: Hany Mohamed Abd El-Lateef Ahmed (Al-Ahsa, SA); Mai Mostafa Khalaf Ali (Al-Ahsa, SA); Antar Ahmed Abdelhamid Ahmed (Sohag, EG); Amer A. Amer (Sohag, EG)
Assignee: KING FAISAL UNIVERSITY
C07D271/10A61P31/04A61P31/10C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,999,706
App. No.
18/486,898
Granted
Jun 4, 2024
Kind
B1
Abstract

A 4-chloro-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide compound, its synthesis, and its use as an antimicrobial agent.

Claims (3)

1. A 4-chloro-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide compound having the formula I:

2. The 4-chloro-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide compound of claim 1 , wherein the compound is obtained as crystals.

3. A pharmaceutically acceptable composition comprising a therapeutically effective amount of the 4-chloro-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide compound of claim 1 and a pharmaceutically acceptable carrier.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2024
From: EL-LATEEF AHMED, HANY MOHAMED ABD; ALI, MAI MOSTAFA KHALAF; ABDELHAMID AHMED, ANTAR AHMED; AMER, AMER A.
To: KING FAISAL UNIVERSITY
Reel/Frame 066339/0692 →